MedTrace Logo

Study of Retinal Findings in People With Signs and Symptoms of Alzheimer s Disease Enrolled in 09-M-0198

NCT02226835 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2018-09-27

No results posted yet for this study

Summary

Background:

\- Alzheimer s disease affects the brain and causes memory and thinking problems in older people. Macular degeneration (MD) is an eye condition. It is the leading reason that people over age 55 in the United States lose their central vision. Central vision is important for seeing fine details and for tasks like reading and driving. A feature of Alzheimer s disease is plaques in the brain. A feature of age-related MD is deposits in the retina in the eye. Researchers want to learn more about these diseases and find out if they are related.

Objective:

\- To see whether there is a relationship between Alzheimer s disease and age-related macular degeneration.

Eligibility:

\- People with or without Alzheimer s disease enrolled in another study. Participants must have someone to help them take part in this study.

Design:

* Participants will be screened through the other study. They will have 1 visit. The tests will take about 3 hours.
* Participants will answer questions about their medical and eye history.
* Participants will have an eye exam to test how well they see. Their eye pressure will be measured and their eye movements will be checked.
* Participants will get eye drops to dilate their pupils. Researchers will take pictures of the retina and the inside of the eye. Researchers may measure the thickness of the retina.
* Participants will continue to receive care from their regular eye doctor during and after the study.

Conditions

  • Age-Related Macular Degeneration
  • Alzheiner's Disease
  • AMD

Sponsors & Collaborators

  • National Eye Institute (NEI)

    lead NIH

Principal Investigators

  • Catherine A Cukras, M.D. · National Eye Institute (NEI)

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-13
Primary Completion
2017-01-24
Completion
2017-01-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02226835 on ClinicalTrials.gov